CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company
Enveric Biosciences, Inc.
Sign in to watch- Ticker
- ENVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954484725
- Phone
- (617) 444-8400
- Business address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
- 4 Open-market buy Director bought 73 shares at $6.51 ($475)
- 4 Open-market buy Director bought 112 shares at $6.51 ($729)
- 4 Open-market buy Director bought 85 shares at an average $6.48 ($551)
- 4 Open-market buy Director bought 127 shares at $6.51 ($827)
- SC 13D/A Stake Beneficial Ownership Report
- 10-KT Report 10-KT
- 4 Open-market buy Director bought 89 shares at $6.00 ($534)
- 4 Open-market buy Director bought 2,600 shares at $6.01 ($15,626)
- 8-K/A Event Acquisition or sale completed
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Executive or director change
- 4 Open-market buy Director bought 5,304 shares at $6.01 ($31,877)
- 4 Open-market buy Director bought 8,032 shares at $6.01 ($48,272)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market buy Director bought 10,631 shares at $6.01 ($63,892)
- 4 Open-market buy Director bought 558 shares at $6.01 ($3,354)
- 4 Open-market buy Director bought 2,759 shares at $6.01 ($16,582)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations
Page 38 of 53 · 1,057 filings